sample	study	cv	added_volume	total_protein	dilution	pathology	mgTP_mLUA
361	240 COHORT		0	10.8	2	Benign	21.50
407	240 COHORT	3	3	14.6	2.0	Benign	29.28
386	240 COHORT	0.75	0.75	11.2	2.0	Benign	22.40
1082	240 COHORT	0.75	0.75	33.1	2.0	Benign	66.10
1035	240 COHORT	0.1	0.1	5.7	2.0	Benign	11.32
425	240 COHORT	0.7	0.7	10.9	2.0	Benign	21.80
389	240 COHORT	3.4	3.4	18.4	2.0	Benign	36.74
544	240 COHORT	0.7	0.7	19.1	2.0	Benign	38.16
1195	240 COHORT	0.2	0.2	11.0	2.0	Benign	22.00
381	240 COHORT	3	3	11.3	2.0	Benign	22.54
148	240 COHORT		0	21.6		Benign	
420	240 COHORT		0	11.2		Benign	
891	240 COHORT	0.5	0.5	19.6	2.0	Benign	39.20
895	240 COHORT	0.2	0.2	6.7	2.0	Benign	13.38
219	240 COHORT		0	6.5		Benign	
328	240 COHORT		0	4.7		Benign	
1097	240 COHORT	0.25	0.25	13.7	2.0	Benign	27.32
1015	240 COHORT	0.15	0.15	7.8	2.0	Benign	15.62
571	240 COHORT	1	1	23.8	2.0	Benign	47.64
941	240 COHORT	0.5	0.5	25.1	2.0	Benign	50.16
870	240 COHORT	0.5	0.5	15.0	2.0	Benign	29.98
360	240 COHORT	1	1	20.3	2.0	Benign	40.50
1143	240 COHORT	0.15	0.15	3.7	2.0	Benign	7.36
1108	240 COHORT	0.5	0.5	10.0	2.0	Benign	19.98
1298	240 COHORT	0.3	0.3	24.5	2.0	Benign	49.08
1042	240 COHORT	0.3	0.3	19.0	2.0	Benign	38.06
1067	240 COHORT	0.1	0.1	8.4	2.0	Benign	16.72
1052	240 COHORT	1	1	20.4	2.0	Endometrial cancer	40.86
1374	240 COHORT	0.25	0.25	15.4	2.0	Benign	30.70
798	240 COHORT	0.5	0.5	15.6	2.0	Benign	31.22
388	240 COHORT	1.2	1.2	24.8	2.0	Benign	49.66
378	240 COHORT	1.5	1.5	11.1	2.0	Benign	22.20
438	240 COHORT	0.6	0.6	20.3	2.0	Benign	40.68
1079	240 COHORT	0.5	0.5	7.6	2.0	Benign	15.14
410	240 COHORT	0.9	0.9	28.0	2.0	Benign	55.94
890	240 COHORT	0.6	0.6	19.2	2.0	Benign	38.46
309	240 COHORT	2	2	9.2	2.0	Benign	18.42
226	240 COHORT		0	12.5		Benign	
220	240 COHORT		0	6.3		Benign	
1165	240 COHORT	0.6	0.6	22.8	2.0	Endometrial cancer	45.56
1358	240 COHORT	0.2	0.2	7.4	2.0	Benign	14.88
1091	240 COHORT		0	10.1		Benign	
1153	240 COHORT	0.25	0.25	16.9	2.0	Endometrial cancer	33.86
551	240 COHORT	1	1	1.4	2.0	Benign	2.80
1092	240 COHORT	0.5	0.5	3.4	2.0	Benign	6.76
409	240 COHORT	0.7	0.7	25.8	2.0	Benign	51.68
1266	240 COHORT	0.4	0.4	25.5	2.0	Endometrial cancer	51.00
1343	240 COHORT	0.4	0.4	7.9	2.0	Benign	15.76
1260	240 COHORT	0.2	0.2	13.5	2.0	Benign	27.04
1278	240 COHORT	0.2	0.2	28.3	2.0	Endometrial cancer	56.58
1070	240 COHORT	0.15	0.15	8.1	2.0	Benign	16.12
428	240 COHORT	1.3	1.3	17.5	2.0	Benign	34.94
242	240 COHORT		0	10.3		Benign	
829	240 COHORT	1.3	1.3	18.3	2.0	Endometrial cancer	36.56
1113	240 COHORT	0.15	0.15	7.3	2.0	Benign	14.60
1259	240 COHORT	0.2	0.2	13.3	2.0	Benign	26.64
230	240 COHORT		0	11.7		Benign	
1094	240 COHORT	0.15	0.15	14.0	2.0	Benign	27.92
1381	240 COHORT	0.4	0.4	22.6	2.0	Benign	45.14
1349	240 COHORT	0.5	0.5	16.1	2.0	Benign	32.14
426	240 COHORT	0.5	0.5	19.4	2.0	Benign	38.86
1096	240 COHORT	0.5	0.5	7.5	2.0	Benign	15.04
LL81	240 COHORT		0	20.6		Endometrial cancer	
LL127	240 COHORT		0	17.6		Endometrial cancer	
812	240 COHORT	0.35	0.35	29.6	2.0	Benign	59.12
885	240 COHORT	0.25	0.25	15.9	2.0	Benign	31.72
868	240 COHORT	0.5	0.5	24.6	2.0	Endometrial cancer	49.16
433	240 COHORT	1.5	1.5	20.1	2.0	Benign	40.16
956	240 COHORT	0.2	0.2	23.1	2.0	Benign	46.24
962	240 COHORT	0.2	0.2	16.2	2.0	Benign	32.48
1010	240 COHORT	1.5	1.5	23.8	2.0	Endometrial cancer	47.62
1053	240 COHORT	0.25	0.25	7.5	2.0	Benign	14.98
1105	240 COHORT	0.5	0.5	9.5	2.0	Benign	18.94
HGC14	240 COHORT	0.6	0.6	8.9	2.0	Endometrial cancer	17.86
1254	240 COHORT	0.4	0.4	17.1	2.0	Benign	34.14
379	240 COHORT	0.5	0.5	13.2	2.0	Benign	26.44
1331	240 COHORT	1.5	1.5	15.3	2.0	Endometrial cancer	30.68
1302	240 COHORT	1.7	1.7	14.8	2.0	Benign	29.52
1202	240 COHORT	0.3	0.3	23.9	2.0	Benign	47.88
901	240 COHORT	0.8	0.8	23.0	2.0	Benign	45.90
1451	240 COHORT	0.5	0.5	23.3	2.0	Benign	46.66
1377	240 COHORT	0.5	0.5	29.0	2.0	Benign	57.96
1244	240 COHORT	0.75	0.75	22.6	2.0	Benign	45.16
LL64	240 COHORT		0	18.0		Endometrial cancer	
1074	240 COHORT	0.6	0.6	20.8	2.0	Endometrial cancer	41.52
1357	240 COHORT	0.25	0.25	8.4	2.0	Benign	16.88
1223	240 COHORT	0.9	0.9	8.7	2.0	Endometrial cancer	17.36
54	240 COHORT	1	1	30.9	2.0	Benign	61.70
1127	240 COHORT	0.25	0.25	22.5	2.0	Benign	44.92
LL36	240 COHORT		0	17.7		Endometrial cancer	
1280	240 COHORT	1	1	24.8	2.0	Endometrial cancer	49.62
356	240 COHORT		0	4.8		Benign	
ICO4	240 COHORT		0	15.0		Benign	
53	240 COHORT	0.6	0.6	15.0	2.0	Benign	30.08
1250	240 COHORT	0.3	0.3	28.9	2.0	Benign	57.78
424	240 COHORT	0.5	0.5	11.9	2.0	Benign	23.70
1027	240 COHORT	0.5	0.5	15.0	2.0	Benign	29.98
971	240 COHORT	0.5	0.5	28.1	2.0	Endometrial cancer	56.12
923	240 COHORT	0.7	0.7	18.5	2.0	Endometrial cancer	37.06
1072	240 COHORT	0.25	0.25	15.6	2.0	Benign	31.12
989	240 COHORT	0.2	0.2	34.0	2.0	Benign	67.94
1231	240 COHORT	1.1	1.1	24.2	2.0	Benign	48.44
986	240 COHORT	0.75	0.75	2.8	2.0	Endometrial cancer	5.62
1023	240 COHORT	0.2	0.2	11.8	2.0	Benign	23.58
830	240 COHORT	1.5	1.5	20.2	2.0	Endometrial cancer	40.46
1446	240 COHORT	3	3	26.5	2.0	Endometrial cancer	52.98
1186	240 COHORT	2	2	12.2	2.0	Endometrial cancer	24.40
LL112	240 COHORT		0	5.0		Endometrial cancer	
HGC18	240 COHORT	1	1	17.3	2.0	Endometrial cancer	34.64
940	240 COHORT	0.25	0.25	14.0	2.0	Benign	27.94
788	240 COHORT	2	2	13.2	2.0	Endometrial cancer	26.38
780	240 COHORT		0	12.5		Endometrial cancer	
1482	240 COHORT	1.1	1.1	24.2	2.0	Endometrial cancer	48.36
1051	240 COHORT	0.3	0.3	8.0	2.0	Benign	16.08
484	240 COHORT	1.8	1.8	28.3	2.0	Benign	56.54
1071	240 COHORT	0.25	0.25	7.2	2.0	Benign	14.44
995	240 COHORT	0.25	0.25	23.9	2.0	Benign	47.72
1061	240 COHORT	1.5	1.5	1.8	2.0	Endometrial cancer	3.64
629	240 COHORT	2.5	2.5	34.6	2.0	Endometrial cancer	69.26
1068	240 COHORT	1	1	11.8	2.0	Endometrial cancer	23.60
1044	240 COHORT	0.5	0.5	6.3	2.0	Endometrial cancer	12.62
1086	240 COHORT	0.3	0.3	13.0	2.0	Benign	25.96
1047	240 COHORT	0.25	0.25	13.7	2.0	Benign	27.36
934	240 COHORT	0.5	0.5	22.7	2.0	Endometrial cancer	45.34
40	240 COHORT		0	19.9		Benign	
382	240 COHORT	1.5	1.5	26.8	2.0	Benign	53.62
1145	240 COHORT	3	3	32.8	2.0	Endometrial cancer	65.52
1277	240 COHORT	0.3	0.3	10.4	2.0	Endometrial cancer	20.80
1245	240 COHORT	0.5	0.5	25.7	2.0	Benign	51.48
LL114	240 COHORT		0	7.8		Endometrial cancer	
1125	240 COHORT	1	1	14.5	2.0	Endometrial cancer	28.92
LL116	240 COHORT		0	13.4		Endometrial cancer	
46	240 COHORT		0	16.8		Benign	
834	240 COHORT	0.6	0.6	24.7	2.0	Endometrial cancer	49.38
952	240 COHORT	0.5	0.5	23.8	2.0	Benign	47.66
959	240 COHORT		0	29.2		Endometrial cancer	
1308	240 COHORT	0.25	0.25	21.3	2.0	Benign	42.56
837	240 COHORT	0.5	0.5	24.3	2.0	Benign	48.66
1136	240 COHORT	0.5	0.5	28.3	2.0	Endometrial cancer	56.56
825	240 COHORT		0	25.6		Benign	
902	240 COHORT	0.5	0.5	17.7	2.0	Endometrial cancer	35.34
417	240 COHORT	0.5	0.5	4.4	2.0	Benign	8.88
980	240 COHORT	0.35	0.35	17.2	2.0	Benign	34.38
984	240 COHORT	0.25	0.25	21.0	2.0	Endometrial cancer	42.04
1347	240 COHORT	1	1	27.4	2.0	Endometrial cancer	54.70
619	240 COHORT	1.8	1.8	9.9	2.0	Endometrial cancer	19.88
HGC10	240 COHORT	0.75	0.75	31.5	2.0	Endometrial cancer	63.00
1121	240 COHORT	1	1	21.0	2.0	Endometrial cancer	42.08
563	240 COHORT	3	3	17.5	2.0	Endometrial cancer	35.04
823	240 COHORT	0.75	0.75	32.3	2.0	Endometrial cancer	64.54
LL85	240 COHORT		0	6.0		Endometrial cancer	
1033	240 COHORT	0.2	0.2	16.9	2.0	Benign	33.72
1215	240 COHORT	0.3	0.3	2.8	2.0	Benign	5.54
771	240 COHORT	6	6	24.1	2.0	Endometrial cancer	48.22
782	240 COHORT	0.75	0.75	28.0	2.0	Endometrial cancer	56.08
ICO12	240 COHORT		0	54.5		Endometrial cancer	
1304	240 COHORT	0.15	0.15	22.9	2.0	Benign	45.74
1009	240 COHORT	4.5	4.5	24.9	2.0	Endometrial cancer	49.88
1288	240 COHORT	0.55	0.55	17.8	2.0	Endometrial cancer	35.58
1056	240 COHORT	1	1	30.6	2.0	Endometrial cancer	61.22
1295	240 COHORT	0.75	0.75	25.4	2.0	Endometrial cancer	50.88
900	240 COHORT	0.6	0.6	29.0	2.0	Benign	58.06
655	240 COHORT	3.6	3.6	24.5	2.0	Endometrial cancer	48.92
LL18	240 COHORT		0	19.7		Endometrial cancer	
936	240 COHORT	1.5	1.5	17.6	2.0	Endometrial cancer	35.14
1077	240 COHORT	1	1	10.5	2.0	Endometrial cancer	21.04
1021	240 COHORT	0.1	0.1	6.1	2.0	Endometrial cancer	12.26
586	240 COHORT	4	4	26.6	2.0	Endometrial cancer	53.16
819	240 COHORT	0.5	0.5	27.8	2.0	Endometrial cancer	55.62
634	240 COHORT	3	3	42.4	2.0	Endometrial cancer	84.72
888	240 COHORT	0.7	0.7	9.5	2.0	Endometrial cancer	18.96
1011	240 COHORT	0.4	0.4	14.0	2.0	Endometrial cancer	27.98
LL124	240 COHORT		0	10.8		Endometrial cancer	
1276	240 COHORT	1	1	21.9	2.0	Endometrial cancer	43.74
1058	240 COHORT	4	4	24.5	2.0	Endometrial cancer	49.04
628	240 COHORT	0.8	0.8	18.4	2.0	Endometrial cancer	36.84
1385	240 COHORT	0.25	0.25	13.3	2.0	Benign	26.66
876	240 COHORT	0.25	0.25	22.9	2.0	Benign	45.84
259	240 COHORT		0	20.8		Endometrial cancer	
1283	240 COHORT	0.3	0.3	19.0	2.0	Benign	37.98
990	240 COHORT	0.25	0.25	12.2	2.0	Endometrial cancer	24.48
1248	240 COHORT	0.4	0.4	4.7	2.0	Benign	9.44
1087	240 COHORT	0.4	0.4	25.8	2.0	Endometrial cancer	51.52
872	240 COHORT	0.75	0.75	59.6	2.0	Benign	119.22
496	240 COHORT	15	15	19.4	2.0	Endometrial cancer	38.70
827	240 COHORT	0.75	0.75	15.2	2.0	Endometrial cancer	30.42
1085	240 COHORT	0.4	0.4	13.9	2.0	Endometrial cancer	27.88
1002	240 COHORT	10.5	10.5	19.0	2.0	Endometrial cancer	37.94
1242	240 COHORT	1.5	1.5	28.1	2.0	Endometrial cancer	56.18
1129	240 COHORT	1.2	1.2	15.6	2.0	Endometrial cancer	31.20
603	240 COHORT	1.5	1.5	11.5	2.0	Endometrial cancer	23.00
1332	240 COHORT	0.3	0.3	17.9	2.0	Benign	35.78
519	240 COHORT	0.75	0.75	40.6	2.0	Endometrial cancer	81.18
1106	240 COHORT	0.5	0.5	12.2	2.0	Benign	24.48
1049	240 COHORT	1.5	1.5	6.5	2.0	Endometrial cancer	13.02
894	240 COHORT	1	1	24.9	2.0	Benign	49.82
731	240 COHORT	1.7	1.7	17.9	2.0	Endometrial cancer	35.72
149	240 COHORT	0.1	0.1	24.6	2.0	Benign	49.10
1110	240 COHORT	2	2	9.7	2.0	Endometrial cancer	19.46
1069	240 COHORT	1	1	14.9	2.0	Endometrial cancer	29.80
831	240 COHORT	1.4	1.4	20.3	2.0	Endometrial cancer	40.58
593	240 COHORT	1	1	22.4	2.0	Endometrial cancer	44.88
1102	240 COHORT	1	1	20.5	2.0	Endometrial cancer	40.94
1185	240 COHORT	2	2	12.5	2.0	Endometrial cancer	25.02
869	240 COHORT	1.5	1.5	34.4	2.0	Endometrial cancer	68.78
1453	240 COHORT	0.1	0.1	22.9	2.0	Endometrial cancer	45.70
594	240 COHORT	3	3	18.3	2.0	Endometrial cancer	36.62
1388	240 COHORT	5.9	5.9	10.6	2.0	Endometrial cancer	21.28
445	240 COHORT	0.5	0.5	16.8	2.0	Endometrial cancer	33.60
1436	240 COHORT	1.1	1.1	13.3	2.0	Endometrial cancer	26.64
725	240 COHORT	1	1	25.4	2.0	Endometrial cancer	50.86
1005	240 COHORT	1.5	1.5	18.4	2.0	Endometrial cancer	36.78
892	240 COHORT	0.9	0.9	23.5	2.0	Benign	46.98
1329	240 COHORT	2	2	31.2	2.0	Endometrial cancer	62.40
765	240 COHORT	1.3	1.3	27.1	2.0	Endometrial cancer	54.18
973	240 COHORT	1	1	20.0	2.0	Endometrial cancer	39.90
1173	240 COHORT	0.3	0.3	21.8	2.0	Benign	43.52
1181	240 COHORT	4.5	4.5	3.9	2.0	Endometrial cancer	7.74
964	240 COHORT	1.5	1.5	23.9	2.0	Endometrial cancer	47.86
1135	240 COHORT	1.1	1.1	15.3	2.0	Endometrial cancer	30.62
808	240 COHORT	0.2	0.2	26.6	2.0	Endometrial cancer	53.12
856	240 COHORT	10	10	34.3	2.0	Endometrial cancer	68.62
1399	240 COHORT	0.5	0.5	27.3	2.0	Endometrial cancer	54.58
1124	240 COHORT	1	1	11.4	2.0	Endometrial cancer	22.70
1081	240 COHORT	0.4	0.4	17.3	2.0	Endometrial cancer	34.68
1258	240 COHORT	0.25	0.25	24.1	2.0	Benign	48.12
1012	240 COHORT	1.2	1.2	21.6	2.0	Endometrial cancer	43.16
1397	240 COHORT	1.4	1.4	24.3	2.0	Endometrial cancer	48.54
ICO7	240 COHORT		0	52.8		Endometrial cancer	
762	240 COHORT	1	1	17.6	2.0	Endometrial cancer	35.12
561	240 COHORT	4	4	38.8	2.0	Endometrial cancer	77.58
1336	240 COHORT	0.6	0.6	14.9	2.0	Endometrial cancer	29.70
632	240 COHORT	3.05	3.05	16.2	2.0	Endometrial cancer	32.48
ICO27	240 COHORT		0	51.5		Endometrial cancer	
1112	240 COHORT	0.75	0.75	58.7	2.0	Endometrial cancer	117.40
LL87	240 COHORT		0	3.8		Endometrial cancer	
1147	240 COHORT	0.7	0.7	30.4	2.0	Endometrial cancer	60.86
1115	240 COHORT	2	2	15.7	2.0	Endometrial cancer	31.36
1197	240 COHORT	0.75	0.75	14.6	2.0	Endometrial cancer	29.16
1078	240 COHORT	2	2	16.5	2.0	Endometrial cancer	32.94
ICO73	240 COHORT		0	14.5		Endometrial cancer	
LL14	240 COHORT		0	13.4		Endometrial cancer	
1491	240 COHORT	0.9	0.9	19.3	2.0	Endometrial cancer	38.58
638	240 COHORT	2.4	2.4	29.7	2.0	Endometrial cancer	59.46
929	240 COHORT	1.8	1.8	14.7	2.0	Endometrial cancer	29.38
1249	240 COHORT	1	1	55.9	2.0	Benign	111.74
1216	240 COHORT	1.5	1.5	29.8	2.0	Endometrial cancer	59.54
ICO30	240 COHORT		0	28.0		Endometrial cancer	
1017	240 COHORT	0.75	0.75	1.2	2.0	Benign	2.34
966	240 COHORT	0.75	0.75	1.5	2.0	Benign	3.04
001-0004	0.5Ml	0.75	0.5	39.36	1.7	Benign	65.60
001-0005	0.5Ml	0.1	0.5	6.82	6.0	Benign	40.92
001-0006	0.5Ml	0.1	0.5	2.92	6.0	Benign	17.52
001-0007	0.5Ml	0.35	0.5	21.29	2.4	Endometrial cancer	51.70
001-0008	0.5Ml	0.1	0.5	2.86	6.0	Benign	17.16
001-0009	0.5Ml	0.1	0.5	1.29	6.0	Benign	7.74
001-0011	0.5Ml	0.1	0.5	7.51	6.0	Benign	45.06
001-0012	0.5Ml	0.05	0.5	6.71	11.0	Benign	73.81
001-0013	0.5Ml	0.1	0.5	2.93	6.0	Benign	17.58
001-0014	0.5Ml	0.05	0.5	9.87	11.0	Benign	108.57
001-0017	0.5Ml	0.05	0.5	8.79	11.0	Benign	96.69
001-0019	0.5Ml	0.1	0.5	4.99	6.0	Benign	29.94
001-0024	0.5Ml	0.05	0.5	1.63	11.0	Benign	17.93
001-0025	0.5Ml	0.05	0.5	0.46	11.0	Benign	5.06
001-0034	0.5Ml	0.1	0.5	7.21	6.0	Endometrial cancer	43.26
001-0040	0.5Ml	0.75	0.5	34.46	1.7	Endometrial cancer	57.43
002-0001	0.5Ml	0.1	0.5	0.76	6.0	Benign	4.56
002-0002	0.5Ml	0.1	0.5	8.4	6.0	Endometrial cancer	50.40
002-0004	0.5Ml	0.2	0.5	0.45	3.5	Endometrial cancer	1.58
002-0005	0.5Ml	0.76	0.5	5.11	1.7	Endometrial cancer	8.47
002-0006	0.5Ml	0.1	0.5	8.65	6.0	Benign	51.90
002-0007	0.5Ml	0.15	0.5	2.86	4.3	Endometrial cancer	12.39
002-0008	0.5Ml	0.1	0.5	22.24	6.0	Benign	133.44
002-0012	0.5Ml	0.2	0.5	11.14	3.5	Endometrial cancer	38.99
002-0013	0.5Ml		0.5	1.44		Benign	
002-0015	0.5Ml	0.25	0.5	4.95	3.0	Endometrial cancer	14.85
002-0016	0.5Ml	0	0.5	0.41		Benign	
002-0018	0.5Ml	0.1	0.5	0.27	6.0	Benign	1.62
002-0019	0.5Ml	0.05	0.5	0.19	11.0	Benign	2.09
002-0020	0.5Ml		0.5	4.19		Benign	
002-0022	0.5Ml	1	0.5	10.76	1.5	Endometrial cancer	16.14
002-0023	0.5Ml	0.25	0.5	12.07	3.0	Endometrial cancer	36.21
002-0024	0.5Ml	0.3	0.5	17.61	2.7	Benign	46.96
002-0025	0.5Ml	0.25	0.5	0.44	3.0	Benign	1.32
002-0026	0.5Ml	0.6	0.5	15.55	1.8	Endometrial cancer	28.51
002-0027	0.5Ml	0.1	0.5	3.7	6.0	Benign	22.20
002-0028	0.5Ml	0.1	0.5	0.57	6.0	Benign	3.42
003-0007	0.5Ml	1	0.5	7.82	1.5	Endometrial cancer	11.73
003-0011	0.5Ml	0.25	0.5	11.32	3.0	Benign	33.96
003-0012	0.5Ml	1	0.5	20.4	1.5	Endometrial cancer	30.60
003-0013	0.5Ml	0.5	0.5	28.44	2.0	Benign	56.88
003-0028	0.5Ml	0.6	0.5	9.65	1.8	Benign	17.69
003-0039	0.5Ml	0.9	0.5	14.8	1.6	Endometrial cancer	23.02
003-0043	0.5Ml	0.9	0.5	25.22	1.6	Endometrial cancer	39.23
003-0044	0.5Ml	1.25	0.5	34.07	1.4	Endometrial cancer	47.70
003-0047	0.5Ml	0.25	0.5	19.86	3.0	Endometrial cancer	59.58
003-0049	0.5Ml	1	0.5	26.36	1.5	Endometrial cancer	39.54
003-0062	0.5Ml	0.25	0.5	11.87	3.0	Endometrial cancer	35.61
004-0001	0.5Ml	0.1	0.5	2.28	6.0	Endometrial cancer	13.68
004-0003	0.5Ml	0.1	0.5	5.09	6.0	Benign	30.54
004-0006	0.5Ml	0.75	0.5	3.47	1.7	Endometrial cancer	5.78
004-0008	0.5Ml	0.05	0.5	3.9	11.0	Benign	42.90
004-0009	0.5Ml	0.05	0.5	5.41	11.0	Benign	59.51
005-0003	0.5Ml	1	0.5	56.51	1.5	Endometrial cancer	84.77
005-0004	0.5Ml	1	0.5	22.4	1.5	Endometrial cancer	33.60
005-0007	0.5Ml	1	0.5	24.85	1.5	Endometrial cancer	37.28
005-0008	0.5Ml	1	0.5	30.99	1.5	Endometrial cancer	46.49
006-0001	0.5Ml	1	0.5		1.5	Endometrial cancer	0.00
006-0009	0.5Ml	1.25	0.5	26	1.4	Endometrial cancer	36.40
007-0002	0.5Ml	0.4	0.5	18.74	2.3	Endometrial cancer	42.17
007-0004	0.5Ml	0.75	0.5	8.78	1.7	Endometrial cancer	14.63
007-0006	0.5Ml		0.5	3.97		Endometrial cancer	
007-0009	0.5Ml	0.25	0.5	5.77	3.0	Endometrial cancer	17.31
007-0010	0.5Ml	0.1	0.5	4.79	6.0	Endometrial cancer	28.74
007-0011	0.5Ml	0.75	0.5	34.13	1.7	Endometrial cancer	56.88
007-0012	0.5Ml	0.75	0.5	8.86	1.7	Endometrial cancer	14.77
007-0013	0.5Ml	0.75	0.5	24.02	1.7	Endometrial cancer	40.03
008-0034	0.5Ml	0.1	0.5	5.62	6.0	Benign	33.72
008-0035	0.5Ml	0.1	0.5	7.96	6.0	Benign	47.76
010-0007	0.5Ml	0.4	0.5	9.79	2.3	Endometrial cancer	22.03
010-0012	0.5Ml	1	0.5	14.79	1.5	Endometrial cancer	22.19
011-0002	0.5Ml	1.25	0.5	29.2	1.4	Endometrial cancer	40.88
011-0032	0.5Ml	0.25	0.5	2.55	3.0	Benign	7.65
012-0001	0.5Ml	1.5	0.5	57.65	1.3	Endometrial cancer	76.87
012-0002	0.5Ml	0.3	0.5	25.02	2.7	Benign	66.72
012-0003	0.5Ml	0.2	0.5	13.81	3.5	Benign	48.34
012-0005	0.5Ml	0.8	0.5	31.83	1.6	Endometrial cancer	51.72
012-0007	0.5Ml	0.4	0.5	15.21	2.3	Benign	34.22
012-0008	0.5Ml	0.5	0.5	35.86	2.0	Benign	71.72
012-0009	0.5Ml	0.25	0.5	14.13	3.0	Benign	42.39
012-0012	0.5Ml	0.25	0.5	14.79	3.0	Benign	44.37
012-0013	0.5Ml	0.05	0.5	3.49	11.0	Benign	38.39
012-0014	0.5Ml	0.55	0.5	10.84	1.9	Endometrial cancer	20.69
012-0015	0.5Ml	0.1	0.5	1.34	6.0	Benign	8.04
012-0016	0.5Ml	0.75	0.5	37.34	1.7	Endometrial cancer	62.23
012-0018	0.5Ml	0.75	0.5	20.14	1.7	Endometrial cancer	33.57
012-0023	0.5Ml	0.25	0.5	17.4	3.0	Benign	52.20
012-0025	0.5Ml	0.75	0.5	55.54	1.7	Benign	92.57
012-0026	0.5Ml	0.5	0.5	34.56	2.0	Benign	69.12
012-0027	0.5Ml	0.1	0.5	3.11	6.0	Benign	18.66
012-0028	0.5Ml	0.1	0.5	1.36	6.0	Benign	8.16
012-0029	0.5Ml	0.75	0.5	35.83	1.7	Benign	59.72
012-0030	0.5Ml	0.1	0.5	1.41	6.0	Benign	8.46
013-0003	0.5Ml	0.5	0.5	15.54	2.0	Benign	31.08
013-0006	0.5Ml	0.75	0.5	26.16	1.7	Endometrial cancer	43.60
014-0026	0.5Ml	0.75	0.5	2.44	1.7	Endometrial cancer	4.07
016-0033	0.5Ml	1.4	0.5	42.76	1.4	Benign	58.03
016-0043	0.5Ml	1	0.5	27.1	1.5	Endometrial cancer	40.65
018-0001	0.5Ml	0.9	0.5	32.03	1.6	Endometrial cancer	49.82
018-0002	0.5Ml	0.25	0.5	12.66	3.0	Endometrial cancer	37.98
018-0006	0.5Ml	0.75	0.5	0.49	1.7	Endometrial cancer	0.82
018-0016	0.5Ml	0.1	0.5	5.1	6.0	Benign	30.60
020-0001	0.5Ml	0.75	0.5	25.56	1.7	Endometrial cancer	42.60
020-0002	0.5Ml	1	0.5	12.21	1.5	Endometrial cancer	18.32
020-0004	0.5Ml	0.3	0.5	1.28	2.7	Endometrial cancer	3.41
020-0006	0.5Ml	0.25	0.5	2.94	3.0	Benign	8.82
020-0007	0.5Ml	0.75	0.5	9.38	1.7	Endometrial cancer	15.63
020-0008	0.5Ml	0.25	0.5	1.06	3.0	Benign	3.18
020-0014	0.5Ml	0.25	0.5	19.2	3.0	Benign	57.60
020-0015	0.5Ml	0.75	0.5	27.38	1.7	Benign	45.63
020-0023	0.5Ml	0.4	0.5	4	2.3	Benign	9.00
020-0034	0.5Ml	0.5	0.5	38.55	2.0	Benign	77.10
020-0037	0.5Ml		0.5	3.55		Benign	
020-0047	0.5Ml	0.5	0.5	3.91	2.0	Endometrial cancer	7.82
020-0049	0.5Ml	0.5	0.5	27.12	2.0	Endometrial cancer	54.24
020-0050	0.5Ml	0.25	0.5	5.24	3.0	Benign	15.72
001-0063	0.5Ml		0.5	38.12		Endometrial cancer	
003-0005	0.5Ml	0.45	0.5	1.01	2.1	Benign	2.13
003-0006	0.5Ml	0.45	0.5	0.76	2.1	Benign	1.60
003-0009	0.5Ml	0.7	0.5	3.11	1.7	Benign	5.33
003-0021	0.5Ml	0.3	0.5	1.14	2.7	Endometrial cancer	3.04
003-0022	0.5Ml	0.5	0.5	12.83	2.0	Endometrial cancer	25.66
003-0051	0.5Ml	0.5	0.5	3.35	2.0	Benign	6.70
003-0056	0.5Ml	0.9	0.5	68.7	1.6	Endometrial cancer	106.87
003-0064	0.5Ml	0.2	0.5	3.72	3.5	Benign	13.02
003-0065	0.5Ml	0.5	0.5	24.82	2.0	Benign	49.64
003-0067	0.5Ml	0.75	0.5	45.35	1.7	Benign	75.58
003-0070	0.5Ml	0.4	0.5	15.49	2.3	Benign	34.85
003-0082	0.5Ml	0.25	0.5	12.79	3.0	Benign	38.37
003-0086	0.5Ml	0.3	0.5	11.9	2.7	Benign	31.73
003-0088	0.5Ml	0.7	0.5	3.46	1.7	Benign	5.93
003-0090	0.5Ml	1.2	0.5	30.16	1.4	Benign	42.73
003-0092	0.5Ml	0.4	0.5	15.29	2.3	Endometrial cancer	34.40
004-0007	0.5Ml	0.5	0.5	20.64	2.0	Endometrial cancer	41.28
005-0009	0.5Ml	0.45	0.5	17.24	2.1	Endometrial cancer	36.40
005-0012	0.5Ml	0.4	0.5	18.92	2.3	Endometrial cancer	42.57
006-0020	0.5Ml	0.25	0.5	0.96	3.0	Benign	2.88
006-0030	0.5Ml	0.3	0.5	1.13	2.7	Benign	3.01
006-0031	0.5Ml	0.4	0.5	15.31	2.3	Benign	34.45
006-0037	0.5Ml	0.4	0.5	2.19	2.3	Endometrial cancer	4.93
006-0045	0.5Ml	0.4	0.5	1.38	2.3	Benign	3.11
009-0026	0.5Ml	0.5	0.5	26	2.0	Endometrial cancer	52.00
013-0047	0.5Ml	0.6	0.5	54.18	1.8	Endometrial cancer	99.33
014-0024	0.5Ml	0.4	0.5	19.08	2.3	Endometrial cancer	42.93
015-0023	0.5Ml	0.75	0.5	41.85	1.7	Endometrial cancer	69.75
015-0048	0.5Ml	0.2	0.5	11.9	3.5	Endometrial cancer	41.65
015-0049	0.5Ml	0.5	0.5	8.42	2.0	Endometrial cancer	16.84
020-0077	0.5Ml	0.75	0.5	33.93	1.7	Endometrial cancer	56.55
012-0207	2mL	0.2	2	2.73	11.0		30.03
012-0211	2mL	0.2	2	1.06	11.0		11.66
012-0208	2mL	0.1	2	0.32	21.0		6.72
012-0215	2mL	0.5	2	15.74	5.0		78.70
012-0205	2mL	0.1	2	5.58	21.0		117.18
012-0209	2mL	0.3	2	10.32	7.7		79.12
008-0018	2mL	0.2	2	1.54	11.0		16.94
008-0038	2mL	1	2	16.35	3.0		49.05
002-0054	2mL	0.1	2	3.53	21.0	Endometrial cancer	74.13
006-0101	2mL	0.25	2	3.59	9.0	Benign	32.31
006-0050	2mL	0.05	2	0.36	41.0	Benign	14.76
024-0005	2mL	1.1	2	16.19	2.8	Otros	45.63
012-0214	2mL	0.1	2	11.96	21.0		251.16
012-0216	2mL	0.2	2	4.56	11.0		50.16
012-0213	2mL	0.1	2	2.32	21.0		48.72
012-0212	2mL	0.25	2	4.26	9.0		38.34
003-0166	2mL	0.4	2	5.84	6.0	Endometrial cancer	35.04
012-0217	2mL	0.1	2	0.11	21.0		2.31
012-0224	2mL	0.05	2	0.12	41.0		4.92
012-0222	2mL	0.25	2	1.95	9.0		17.55
012-0220	2mL	0.5	2	23.99	5.0		119.95
012-0221	2mL	0.1	2	1.30	21.0		27.30
012-0223	2mL	0.05	2	0.35	41.0		14.35
012-0219	2mL	0.25	2	6.83	9.0		61.47
012-0226	2mL	0.1	2	2.15	21.0		45.15
012-0230	2mL	0.25	2	2.45	9.0		22.05
012-0229	2mL	0.75	2	0.43	3.7		1.58
012-0231	2mL	0.01	2		201.0		0.00
012-0228	2mL	0.5	2	5.72	5.0		28.60
012-0225	2mL	0.1	2	1.11	21.0		23.31
012-0227	2mL	0.2	2	3.19	11.0		35.09
037-0004	2mL	0.1	2	1.15	21.0	Benign	24.15
037-0005	2mL	0.25	2	3.26	9.0	Benign	29.34
011-0022	2mL	0.75	2	14.18	3.7	Endometrial cancer	51.99
011-0081	2mL	0.75	2	5.82	3.7	Benign	21.34
011-0099	2mL	1	2	13.17	3.0	Endometrial cancer	39.51
024-0009	2mL	0.1	2	0.85	21.0	Benign	17.85
006-0102	2mL	0.25	2	1.12	9.0	Benign	10.08
024-0027	2mL	0.5	2	4.45	5.0		22.25
006-0104	2mL	0.05	2	0.64	41.0	Benign	26.24
006-0103	2mL	0.2	2	1.47	11.0	Benign	16.17
011-0015	2mL	0.7	2	3.83	3.9	Endometrial cancer	14.77
012-0232	2mL	0.25	2	4.11	9.0		36.99
012-0233	2mL	0.1	2	1.05	21.0		22.05
012-0234	2mL	0.2	2	1.17	11.0		12.87
012-0236	2mL	0.1	2	2.18	21.0		45.78
012-0238	2mL	0.4	2	6.08	6.0		36.48
012-0237	2mL	0.1	2	0.65	21.0		13.65
012-0235	2mL	0.1	2	0.98	21.0		20.58
007-0022	2mL	0.1	2	1.79	21.0		37.59
003-0155	2mL	0.2	2	1.56	11.0	Benign	17.16
003-0163	2mL	0.3	2	2.38	7.7	Endometrial cancer	18.25
003-0170	2mL	0.3	2	7.57	7.7	Benign	58.04
003-0165	2mL	0.1	2	0.43	21.0	Benign	9.03
003-0167	2mL	0.4	2	1.45	6.0	Endometrial cancer	8.70
003-0162	2mL	0.25	2	4.06	9.0		36.54
002-0053	2mL	0.05	2	0.31	41.0	Benign	12.71
002-0055	2mL	0.1	2	0.12	21.0	Benign	2.52
002-0056	2mL	0.1	2	3.71	21.0	Endometrial cancer	77.91
002-0057	2mL	0.1	2	0.19	21.0	Hiperplasia at√≠pica endometrial	3.99
009-0097	2mL	0.75	2	3.18	3.7		11.66
011-0068	2mL	0.1	2	1.00	21.0		21.00
009-0083	2mL	1.25	2	5.24	2.6		13.62
024-0008	2mL	0.1	2	0.31	21.0	Benign	6.51
012-0246	2mL	0.5	2	20.51	5.0		102.55
012-0242	2mL	0.1	2	0.85	21.0		17.85
011-0018	2mL	0.5	2	5.79	5.0	Endometrial cancer	28.95
012-0245	2mL	0.01	2	0.18	201.0		36.18
012-0244	2mL	0.2	2	0.81	11.0		8.91
012-0240	2mL	0.2	2	1.17	11.0		12.87
012-0241	2mL	0.25	2	13.71	9.0		123.39
012-0239	2mL	1.25	2	11.28	2.6		29.33
011-0016	2mL	0.6	2	5.38	4.3	Endometrial cancer	23.31
012-0243	2mL	0.2	2	4.24	11.0		46.64
011-0017	2mL	0.5	2	2.02	5.0	Endometrial cancer	10.10
003-0076	2mL	0.25	2	3.12	9.0	Benign	28.08
003-0143	2mL	0.5	2	3.00	5.0		15.00
007-0023	2mL	0.75	2	8.88	3.7		32.56
003-0138	2mL	0.6	2	11.65	4.3	Endometrial cancer	50.48
003-0168	2mL	0.2	2	41.30	11.0	Benign	454.30
003-0156	2mL	0.1	2	1.13	21.0	Endometrial cancer	23.73
012-0247	2mL	0.1	2	0.58	21.0		12.18
007-0024	2mL	1	2	8.61	3.0		25.83
006-0108	2mL	0.8	2	11.13529903	3.5	Endometrial cancer	38.97
006-0107	2mL	0.25	2	2.714269917	9.0	Otros	24.43
006-0106	2mL	0.1	2	1.150939185	21.0	Benign	24.17
006-0105	2mL	0.2	2	0.892116209	11.0	Benign	9.81
008-0039	2mL	1	2	8.910294766	3.0		26.73
003-0135	2mL	0.3	2	9.189455769	7.7	Endometrial cancer	70.45
003-0151	2mL	1	2	1.29822019	3.0	Endometrial cancer	3.89
003-0161	2mL	0.25	2	3.37584743	9.0	Endometrial cancer	30.38
009-0084	2mL	0.3	2	4.438573131	7.7		34.03
008-0016	2mL	0.25	2	2.340827811	9.0		21.07
002-0058	2mL	0.2	2	1.679094027	11.0	Endometrial cancer	18.47
002-0059	2mL	0.05	2	0.140464167	41.0	Endometrial cancer	5.76
003-0123	2mL	2	2	19.7462007	2.0		39.49
030-0022	2mL	0.75	2	12.30803342	3.7		45.13
012-0254	2mL	0.4	2	15.63312806	6.0		93.80
012-0253	2mL	0.01	2	0.596336301	201.0		119.86
012-0252	2mL	1	2	17.65654848	3.0		52.97
012-0249	2mL	1	2	12.07954547	3.0		36.24
012-0255	2mL	0.75	2	11.20215877	3.7		41.07
012-0248	2mL	1	2	7.276607441	3.0		21.83
012-0250	2mL	0.25	2	2.754523092	9.0		24.79
012-0251	2mL	0.5	2	11.65069544	5.0		58.25
009-0021	2mL	0.75	2	11.77464468	3.7		43.17
012-0256	2mL	0.1	2	5.707429857	21.0		119.86
024-0011	2mL	0.5	2	2.339223412	5.0	Endometrial cancer	11.70
011-0021	2mL	0.2	2	1.449785543	11.0	Endometrial cancer	15.95
011-0069	2mL	0.05	2	0.327571374	41.0		13.43
006-0110	2mL	0.05	2	0.261818733	41.0	Benign	10.73
006-0109	2mL	0.75	2	6.858863659	3.7	Endometrial cancer	25.15
011-0071	2mL	0.01	2	0.19332234	201.0		38.86
002-0060	2mL	0.4	2	4.941638385	6.0	Endometrial cancer	29.65
002-0061	2mL	0.1	2	0.996799232	21.0	Endometrial cancer	20.93
002-0064	2mL	0.4	2	6.605819175	6.0	Endometrial cancer	39.63
003-0124	2mL	0.2	2	18.49157871	11.0	Endometrial cancer	203.41
006-0112	2mL	0.1	2	1.4762346	21.0	Benign	31.00
006-0111	2mL	0.1	2	0.878910773	21.0	Benign	18.46
005-0020	2mL	0.3	2	6.267750697	7.7	Endometrial cancer	48.05
009-0079	2mL	0.9	2	8.524436088	3.2		27.47
015-0038	2mL	0.8	2	0.617976332	3.5	Endometrial cancer	2.16
020-0069	2mL	1.1	2	13.78739897	2.8		38.86
012-0257	2mL	0.1	2	1.972236055	21.0		41.42
012-0264	2mL	0.1	2	1.860554047	21.0		39.07
012-0262	2mL	0.2	2	1.3219297	11.0		14.54
012-0258	2mL	1	2	1.530577225	3.0		4.59
020-0173	2mL	0.3	2	1.242205871	7.7		9.52
020-0184	2mL	0.8	2	12.95433668	3.5		45.34
012-0261	2mL	0.1	2	3.276283913	21.0		68.80
012-0260	2mL	0.2	2	2.891489363	11.0		31.81
012-0265	2mL	1.1	2	8.616738638	2.8		24.28
012-0259	2mL	0.1	2	1.375411473	21.0		28.88
012-0263	2mL	0.25	2	0.348767575	9.0		3.14
005-0021	2mL	1	2	5.729688602	3.0	Endometrial cancer	17.19
003-0164	2mL	0.1	2	0.659894371	21.0	0	13.86
003-0033	2mL	0.4	2	6.559254115	6.0	0	39.36
030-0035	2mL	0.7	2	1.55096398	3.9		5.98
012-0272	2mL	0.25	2	4.898996248	9.0		44.09
012-0269	2mL	0.2	2	0.666797489	11.0		7.33
012-0267	2mL	0.2	2	2.75970532	11.0		30.36
012-0266	2mL	0.2	2	0.789528366	11.0		8.68
012-0270	2mL	0.1	2	0.904387147	21.0		18.99
012-0268	2mL	0.25	2	0.427711748	9.0		3.85
012-0271	2mL	0.25	2	1.895368497	9.0		17.06
012-0273	2mL	0.1	2	0.120224123	21.0		2.52
003-0160	2mL	0.25	2	0.097540935	9.0		0.88
003-0130	2mL	0.5	2	3.373384321	5.0	Endometrial cancer	16.87
037-0007	2mL	0.01	2	0.127218623	201.0	0	25.57
012-0274	2mL	0.1	2	0.588729307	21.0		12.36
012-0277	2mL	0.05	2	0.10712419			
012-0276	2mL	0.05	2	0.161541661	41.0		6.62
012-0275	2mL	0.25	2	2.657736938	9.0		23.92
006-0113	2mL	0.4	2	3.970614469	6.0	Endometrial cancer	23.82